Next-generation sequencing role in pharmacogenetics and pharmacogenomics
Next-generation sequencing (NGS) represents an efficient and reliable method to evaluate the contribution of both common and rare...
top of page
Jan 22
NGS in clinical histocompatibility testing
The human leukocyte antigen (HLA) region is one of the most researched parts of the human genome due to the fact multiple vital genes for...
Sep 13, 2023
The link between proteogenomics and the advancement in precision medicine
The emerging discipline of proteogenomics arose from the combination of two molecular biology fields – mass spectrometry (MS)-based...
Aug 27, 2022
Genetic research and diagnosis of Endometriosis
Endometriosis is a gynaecological disease affecting around 10% of women of reproductive age. The main symptoms of endometriosis are pain...
Aug 27, 2022
Genome-first approach to mendelian cardiovascular disease
Since the 1990s cardiovascular genomics has been a popular area of research, heading toward a genome-first approach to the diagnosis and...
Aug 27, 2022
WES and WGS as Cost-Effective Prenatal Tests
egSEQ Technology Whole exome sequencing (WES) and Whole genome sequencing (WGS) have been increasingly adopted as the primary prenatal...
Aug 23, 2022
Supporting the government of the Czech Republic’s State Material Reserves with ActivXpress+
Working with the State Material Reserves of the government of the Czech Republic, our ActivXpress+ diagnostic products have been used in...
Aug 23, 2022
The role of egSEQ Exome in the research and diagnosis of Parkinson’s diseases
Neurology researchers are utilising our market-leading egSEQ library preparation and Exome solutions to understand genetic risk factors...
Aug 22, 2022
Access to genetic testing and the role of effective genetic counselling
Although it is widely accepted that genetic testing is an important tool to aid early diagnosis in some patient cohorts, studies have...
Aug 22, 2022
NGS testing for CYP gene and variation in drug responses
Among the most researched pharmacogenes is the CYP gene superfamily (Fukunaga et al., 2021), which influences drug-metabolising enzymes...
Aug 22, 2022
Oncology targeted therapy with egSEQ NGS
Personalised diagnostic and precision medicine for cancer patients involves tailoring each patient’s treatment based on the genomic...
Aug 22, 2022
Recurrence monitoring of colorectal and breast cancer patients with egSEQ Comprehensive Solid Tumour
With the continuous discovery of genetic targets correlated with recurrence risk, time to recurrence (TTC) and/or overall survival, it is...
bottom of page